移植对比慢性输血改善无卒中镰状细胞贫血儿童狭窄结局
DREPAGREFFE 试验比较造血干细胞移植与标准治疗(慢性输血至少1年)在60例无卒中镰状细胞贫血且经颅多普勒异常儿童中的3年狭窄结局。
要点
- 移植后无新发狭窄,标准治疗组有2例新发狭窄。
- 标准治疗组狭窄评分保持稳定,移植组显著改善。
核心结论
- 在无卒中镰状细胞贫血儿童中,移植较慢性输血可改善3年狭窄结局并预防新发狭窄。
研究设计与样本
- DREPAGREFFE 试验纳入60例无卒中镰状细胞贫血且经颅多普勒异常的儿童,比较造血干细胞移植与标准治疗(慢性输血至少1年)。
主要发现
- 移植后无新发狭窄,标准治疗组有2例新发狭窄。
临床怎么用
- 对有配型同胞供者的无卒中镰状细胞贫血且经颅多普勒异常儿童,可考虑移植以改善狭窄结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report here the 3-year stenosis outcome in 60 stroke-free children with sickle cell anaemia (SCA) and an abnormal transcranial Doppler history, enrolled in the DREPAGREFFE trial, which compared stem cell transplantation (SCT) with standard-care (chronic transfusion for 1-year minimum). Twenty-eight patients with matched sibling donors were transplanted, while 32 remained on standard-care. Stenosis scores were calculated after performing cerebral/cervical 3D time-of-flight magnetic resonance angiography. Fourteen patients had stenosis at enrollment, but only five SCT versus 10 standard-care patients still had stenosis at 3 years. Stenosis scores remained stable on standard-care, but significantly improved after SCT (P = 0·006). No patient developed stenosis after SCT, while two on standard-care did, indicating better stenosis prevention and improved outcome after SCT.
引用
- Verlhac S, Gabor F, Paillard C, et al. Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion. Br J Haematol. 2020. PMID: 33216975. doi:10.1111/bjh.17178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。